These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6447296)

  • 1. Neuropsychiatric implications of drugs acting on dopamine receptors: the effect of apomorphine.
    Corsini GU; Bernardi F; Marrosu F; Gessa GL
    Prog Clin Biol Res; 1980; 39():225-37. PubMed ID: 6447296
    [No Abstract]   [Full Text] [Related]  

  • 2. Apomorphine as a preferential stimulant of self-inhibitory dopamine receptors in man.
    Corsini GU; Del Zompo M; Piccardi MP; Mangoni A; Gessa GL
    Ann Ist Super Sanita; 1978; 14(1):123-30. PubMed ID: 756167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scopolamine-induced hypermotility in rats is mediated via a dopaminergic system.
    Fink H; Morgenstern R
    Acta Biol Med Ger; 1980; 39(8-9):903-10. PubMed ID: 7282220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuropharmacology of apomorphine (review of the literature)].
    Zharkovskiĭ AM; Allikmets LKh
    Farmakol Toksikol; 1981; 44(2):226-32. PubMed ID: 7023969
    [No Abstract]   [Full Text] [Related]  

  • 5. Apomorphine: a rapid rescue agent for the management of motor fluctuations in advanced Parkinson disease.
    Kolls BJ; Stacy M
    Clin Neuropharmacol; 2006; 29(5):292-301. PubMed ID: 16960475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apomorphine continuous stimulation in Parkinson's disease: receptor desensitization as a possible mechanism of reduced motor response.
    Maggio R; Barbier P; Corsini GU
    J Neural Transm Suppl; 1995; 45():133-6. PubMed ID: 8748618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-dependent effects of antidepressant drugs on the low dose of apomorphine-induced locomotor hypoactivity in rats.
    Dziedzicka-Wasylewska M; Rogóz Z
    Pol J Pharmacol; 1997; 49(5):337-43. PubMed ID: 9566033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditioned dopaminergic activity.
    Schiff SR
    Biol Psychiatry; 1982 Feb; 17(2):135-54. PubMed ID: 7200377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hallucinogen caused motility disorders in rats as potential psychosis relevant animal model].
    Oelssner W
    Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():53-60. PubMed ID: 7157125
    [No Abstract]   [Full Text] [Related]  

  • 10. The locomotor and stereotype response to dopaminergic drugs and caffeine after intracerebroventricular kainic acid in rats.
    Kleinrok Z; Turski L; Wawrzyniak M; Cybulska R
    Pol J Pharmacol Pharm; 1981; 33(2):149-59. PubMed ID: 7198226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascorbic acid effect on ethanol sensitivity via possible dopaminergic mediation.
    Yanai J; Fishman RH; Mittleman L
    Subst Alcohol Actions Misuse; 1984; 5(4):169-74. PubMed ID: 6523349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between agents stimulating and inhibiting the central dopamine receptors and octopamine.
    Jagiełło-Wójtowicz
    Acta Physiol Pol; 1980; 31(2):153-8. PubMed ID: 6771963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relief of akinesia by apomorphine and cerebral metabolic changes in Parkinson's disease.
    Broussolle E; Cinotti L; Pollak P; Landais P; Le Bars D; Galy G; Lavenne F; Khalfallah Y; Chazot G; Mauguière F
    Mov Disord; 1993 Oct; 8(4):459-62. PubMed ID: 8232355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic and cholinergic influences on motor behavior in chickens.
    Sanberg PR
    J Comp Psychol; 1983 Mar; 97(1):59-68. PubMed ID: 6872506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large stem cell grafts could lead to erroneous interpretations of behavioral results?
    Christophersen NS; Brundin P
    Nat Med; 2007 Feb; 13(2):118; author reply 118-9. PubMed ID: 17290262
    [No Abstract]   [Full Text] [Related]  

  • 16. Large stem cell grafts could lead to erroneous interpretations of behavioral results?
    Goldman SA; Roy NS; Beal MF; Cleren C
    Nat Med; 2007 Feb; 13(2):118-9. PubMed ID: 17290261
    [No Abstract]   [Full Text] [Related]  

  • 17. Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: implications for prevention or treatment of tardive dyskinesia.
    Fuller RW; Clemens JA; Hynes MD
    J Clin Psychopharmacol; 1982 Dec; 2(6):371-5. PubMed ID: 7174859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?
    Dépatie L; Lal S
    J Psychiatry Neurosci; 2001 May; 26(3):203-20. PubMed ID: 11394190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motor response to a dopamine D3 receptor preferring agonist compared to apomorphine in levodopa-primed 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.
    Blanchet PJ; Konitsiotis S; Chase TN
    J Pharmacol Exp Ther; 1997 Nov; 283(2):794-9. PubMed ID: 9353400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of dyskinesias.
    Mov Disord; 1990; 5(3):265-6. PubMed ID: 2388648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.